Adult Respiratory Distress Syndrome: A Radical Perspective

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 457-490

  Louie, Samuel ^a   Halliwell, Barry ^a,b   Cross, Carroll Edward ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956765492     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60995-3     Document Type: Article

References (197)

1. Abraham E., Wunderink R., Silverman H., et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. JAMA 273 (1995) 934-941
2. Anzueto A., Baughman R., Guntupalli K., et al. An international randomized placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS. Am. J. Respir. Crit. Cure Med. 149A (1994) A567
3. Armstrong L., Jordan N., and Millar A. Interleukin 10 (IL-10) regulation of tumour necrosis factor a (TNF-α) from human alveolar macrophages and peripheral blood mono-cytes. Thorax 51 (1996) 143-149
4. Asbaugh D.G., Bigelow D.B., Petty T.L., and Levine B.E. Acute respiratory distress in adults. Lancet 2 (1967) 319-323
5. Bachofen M., and Weibel E.R. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med. 3 (1982) 35-56
6. Baldwin S.R., Gun C.M., Boxer L.A., Simon R.H., Ketai L.H., and Devall L.J. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1 (1986) 11-14
7. Balla A.K., Doi E.M., Wunder P.R., Ogle J.D., and Debault L.E. Human polymorphonuclear leukocyte (PMN) priming and activation by acute ethanol intoxication. Adv. Exp. Med. Biol. 335 (1993) 165-168
8. Barlett D., Church D.F., Bounds P.L., and Koppenol W.H. The kinetics of the oxidation of L-ascorbic acid by peroxynitrite. Free Rad. Biol. Med. 18 (1995) 85-92
9. Baumgartner J.D., Glauser M.P., Mccutchan J.A., et al. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 2 (1985) 59-63
10. Beal A.L., and Cerra F.B. Multiple organ failure syndrome in the 1990s: Systemic inflammatory response and organ dysfunction. JAMA 271 (1994) 226-233
11. Beckman J.S., Beckman T.W., Chen J., et al. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1620-1624
12. Bell R.C., Coalson J.J., Smith J.D., and Johanson W.G. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann. Intern. Med. 99 (1983) 293-298
13. Bernard G.R. Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome. Eur. Respir. J. 3 11 (1990) 496s-498s
14. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149 (1994) 88-824
15. Bernard G.R., Luce J.M., Sprung C.L., et al. High dose corticosteroids in patients with adult respiratory distress syndrome. N. Engl. J. Med. 317 (1987) 1565-1570
16. Bernard G.R., Lucht W.D., Niedermeyer M.E., et al. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J. Clin. Invest. 73 (1984) 1772-1784
17. Beutler B., Milsark I.W., and Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science 229 (1985) 869-871
18. Billiau A., and Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21 (1991) 559-573
19. Bone R.C. Gram positive organisms and sepsis. Arch. Intern. Med. 154 (1994) 26-34
20. Bone R.C., Balk R.A., Fein A.M., et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial. Crit. Care Med. 23 (1995) 994-1005
21. Bone R.C., Balk R.A., Slotman G., et al. Adult respiratory distress syndrome: Sequence and importance of development of multiple organ failure. Chest 101 (1992) 320-326
22. Bone R.C., Slotman G., Maunder R., et al. Randomized double-blind multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Chest 96 (1989) 114-119
23. Braquet P., Touqui L., Shen T.Y., and Vargaftig B.B. Perspectives in platelet-activating research. Pharmacol. Rev. 39 (1987) 97-145
24. Braughler J.M., Hall E.D., Jacobsen E.J., Mccall J.M., and Means E.D. The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14 (1989) 143-152
25. Bunnell E., and Pacht E.R. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148 (1993) 1174-1178
26. Cannon J.G., Tompkins R.G., Gelfand J.A., et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161 (1990) 79-84
27. Cochrane C.G., Spragg R.G., Revak S.D., et al. The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 127 (1983) 525-527
28. Cross A.S. Antiendotoxin antibodies: A dead end?. Ann. Intern. Med. 121 (1994) 58-60
29. Cross A.S., Opal S.M., Palardy J.E., et al. The efficacy of combination immunother-apy in experimental. Pseudomonas sepsis. J. Infect. Dis. 176 (1993) 112-118
30. Cross C.E., Forte T., Stocker R., et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J. Lab. Clin. Med. 115 (1990) 396-404
31. Cross C.E., Van Der Vliet A., O'Neill C.A., and Eiserich J.P. Reactive oxygen species and the lung. Lancet 344 (1984) 930-933
32. Curzen N.P., Griffiths M.J.D., and Evans T.W. Role of endothelium in modulating the vascular response to sepsis. Clin. Sci. 86 (1994) 359-374
33. Damas P., Reuter A., Gysen P., Demonty J., Lamy M., and Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17 (1989) 975-978
34. Darley-Usmar V., Wiseman H., and Halliwell B. Nitric oxide and oxyen radicals: A question of balance. FEBS Lett. 369 (1995) 131-135
35. Davis W.B., Rennard S.I., Bitterman P.B., and Crystal R.G. Pulmonary oxygen toxicity: Early reversible changes in human alveolar structures induced by hyperoxia. N. Engl. J. Med. 309 (1983) 878-883
36. Dehring D.J., and Wismar B.L. Intravascular macrophages in pulmonary capillaries of humans. Am. Rev. Respir. Dis. 139 (1989) 1027-1029
37. Dernling R.H., Lalonde C., Ryan P., et al. Endotoxemia produces an increase in arterial but not venous lipid peroxides in sheep. J. Appl. Physiol. 64 (1988) 592-598
38. Dobrina A., and Patriaraca P. Neutrophil-endothelial cell interaction. J. Clin. Invest. 78 (1986) 462-471
39. Donnelly S.C. Role of selectins in development of adult respiratory distress syndrome. Lancet 344 (1994) 215-219
40. Dorinsky P.M., and Gadek J.E. Mechanisms of multiple nonpulmonary organ failure in ARDS. Chest 96 (1989) 885-892
41. Doyle R.L., Szaflarski N., Modin G.W., et al. Identification of patients with acute lung injury: Predictors of mortality. Am. J. Respir. Crit. Care Med. 152 (1995) 1818-1824
42. Enhorning G. Surfactant replacement in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140 (1989) 281-283
43. Faull R.J. Adhesion molecules in health and disease. Aust. N.Z. J. Med. 25 (1995) 720-730
44. Folkes L.K., Candeias L.P., and Wardman P. Kinetics and mechanism of hypochlorous acid reactions. Arch. Biochem. Biophys. 323 (1995) 120-126
45. Fowler A.A., Hamman R.F., Zerbe G.O., Benson K.N., and Hyers T.M. Adult respiratory distress syndrome. Prognosis after onset. Am. Rev. Respir. Dis. 132 (1985) 472-478
46. Frank L., Summerville F.L., and Massaro D. Protection from oxygen toxicity with endotoxin: Role of the endogenous antioxidant enzymes of the lung. J. Clin. Invest. 65 (1980) 1104-1110
47. Freeman B.A., and Crapo J.D. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 256 (1981) 10986-10992
48. Freeman B.A., and Panus P.C. Specific modulation of alveolar type II epithelial α-tocopherol content. Am. Rev. Respir. Dis. 137 (1988) A84
49. Galley H.F., Davies M.J., and Webster N.R. Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading. Free Rad. Biol. Med. 20 (1996) 139-143
50. Gee M.H., Perkowski S.Z., Tahamont M.V., and Flynn J.T. Arachidonatecyclooxygenase metabolites as mediators of complement-initiated lung injury. Fed. Proc. 44 (1985) 46-52
51. Gerschman R., Gilbert D.L., Nye S.W., Dwyer P., and Feen W.O. Oxygen poisoning and x-irradiation: A mechanisms in common. Science 119 (1954) 623-626
52. Giroir B.P. Mediators of septic shock: New approaches for interrupting the endogenous inflammatory cascade. Crit. Care Med. 21 (1993) 780-789
53. Ghofrani H.A., Rosseau S., Walmrath D., Kadus W., Kramer A., Grimminger F., Lohmeyer J., and Seeger W. Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. Am. J. Physiol. 270 (1996) L62-L68
54. Gnidec A.G., Sibbald W.J., Cheung H., and Metz C.A. Ibuprofen reduces the progression of permeability edema in an animal model of hyperdynamic sepsis. J. Appl. Physiol. 65 (1988) 1024-1032
55. Goldblum S.E., Jay M., Yoneda K., Cohen D.A., Mcclain C.J., and Gillespie M.N. Monokine-induced acute lung injury in rabbits. J. Appl. Physiol. 63 (1987) 2093-2100
56. Griffith D.E., Holden W.E., Morris J.F., Min L.K., and Krishnamurthy G.T. Effect of common therapeutic concentrations of oxygen on lung clearance of Tc-DPTA and bronchoalveolar lavage albumin concentration. Am. Rev. Respir. Dis. 134 (1986) 233-237
57. Groeneveld A.B.J., Raijmakers P.G.H.M., and Hack C.E. Interleukin 8-related neutrophil elastase and the severity of the adult respiratory tract syndrome. Cytokine 7 (1995) 746-752
58. Grum C.M., Ragsdale R.A., Ketai L.H., et al. Plasma xanthine oxidase activity in patients with adult respiratory distress syndrome. J. Crit. Cure 2 (1987) 22-26
59. Gutteridge J.M.C., Quinlan G.J., and Evans T.W. Transient iron overload with bleomycin detectable iron in the plasma of patients with ARDS. Thorax 49 (1994) 707-710
60. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94 (1994) 2407-2413
61. Haddad I.Y., Zhu S., Ischiropoulos H., and Matalon S. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am. J. Physiol. 270 (1996) L281-L288
62. Halliwell B. Drug antioxidant effects: A basis for drug selection?. Drugs 42 (1991) 569-605
63. Halliwell B., and Gutteridge J.M.C. "Free Radicals in Biology and Medicine". 2nd Ed. (1989), Clarendon Press, Oxford
64. Halliwell B., Gutteridge J.M.C., and Cross C.E. Free radicals, antioxidants, and human disease: Where are we now?. J. Lab. Clin. Med. 119 (1992) 598-620
65. Haupt M.T., Jastremski M.S., Clemmer T.P., Metz C.A., and Goris G.B. The ibuprofen study group: Effect of ibuprofen in patients with severe sepsis. A randomized, double-blind, multicenter study. Crit. Care Med. 19 (1991) 1339-1347
66. Heffner J.E., Sahn S.A., and Repine J.E. The role of platelets in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 136 (1987) 482-492
67. Holtzman M.J. State of the art: Arachidonic acid metabolism. Am. Rev. Respir. Dis. 143 (1991) 188-203
68. Holzapfel L., Robert D., Perrin F., Gaussorgues P., and Giudicelli D.P. Comparison of high-frequency jet ventilation to conventional ventilation in adults with respiratory distress syndrome. Intensive Care Med. 13 (1987) 100-105
69. Hu M.L., Louie S., Cross C.E., Motchnik P., and Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med. 121 (1993) 257
70. Hu P., Ischiropoulos H., Beckman J.S., and Matalon S. Peroxynitrite inhibition of oxygen consumption and ion transport in alveolar type II cells. Am. J. Physiol. 266 (1994) L628-L634
71. Hudson L.D. New therapies for ARDS. Chest 108 Suppl. (1995) 74S-91S
72. Hudson L.D., Milberg J., Anardi D., et al. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151 (1995) 293-301
73. Huie R.E., and Padmaja S. The reaction of nitric oxide with superoxide. Free Rad. Res. Commun. 18 (1993) 195-199
74. Hyers T.M., Tricomi S.M., Dettenmeier P.A., and Fowler A.A. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144 (1991) 268-271
75. Ischiropoulos H., Zhu L., and Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298 (1992) 446-451
76. Jacobs R.F., Tabor D.R., Burks A.W., and Campbell G.D. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140 (1989) 1686-1692
77. Jamieson D. Oxygen toxicity and reactive oxygen metabolites in mammals. Free Rad. Biol. Med. 7 (1989) 87-108
78. Jenkins J.K., Carey P.D., Bryne K., Sugerman H.J., and Fowler A.A. Sepsis-induced lung injury and the effects of ibuprofen pretreatment. Am. Rev. Respir. Dis. 143 (1991) 155-161
79. Jenkinson S.G., Roberts R.J., Delemos R.A., et al. Allopurinol-induced effects in premature baboons with respiratory distress syndrome. J. Appl. Physiol. 70 (1991) 1160-1167
80. Jepsen S., Herlevsen P., Knudsen P., Bud M.I., and Klausen N.O. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective randomized, placebo-controlled study. Crit. Care Med. 20 (1992) 918-923
81. Krafft P., Fridrich P., Fitzgerald R.D., Koc D., and Steltzer H. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109 (1996) 486-493
82. Kennedy T.P., Rao N.V., Hopkins C., Pennington L., Tolley E., and Hoidal J.R. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J. Clin. Invest. 83 (1989) 1326-1335
83. Kim D.K., Fukuda T., Thompson T., et al. Bronchoalveolar lavage fluid phospholipid A2 activities are increased in human adult respiratory distress syndrome. Am. J. Physiol. 169 (1995) L109-L118
84. Koyama I., Toung T.J.K., Rogers M.C., et al. Oxygen radicals mediate reperfusion lung injury in ischemic oxygen-ventilated canine pulmonary lobe. J. Appl. Physiol. 63 (1987) 111-115
85. Krafft P., Fridrich P., Fitzgerald R.D., et al. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109 (1996) 486-493
86. Krieger B.P., Loomis W.H., and Spragg R.G. Granulocytes and hyperoxia act synergistically in causing acute lung injury. Exp. Lung Res. 7 (1984) 77-83
87. Kulkarni A.B., Huh C.-G., Becker D., et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 770-774
88. Kunkel S.L., Standiford T., Kasahara K., and Strieter R.M. Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp. Lung Res. 17 (1991) 17-23
89. Lalonde C., Ikegami K., and Demling R. Aerosolized deferoxamine prevents lung and systemic injury caused by smoke inhalation. J. Appl. Physiol. 77 (1994) 2057-2064
90. Larrick J.W., and Wright S.C. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4 (1990) 3215-3223
91. Laubach V.E., Shesley E.G., Smithies O., and Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10688-10692
92. Laurent T., Markert M., Von Fliedner V., et al. CD11b/CD18 expression adherence, and chemotaxis of granulocytes in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 149 (1994) 1534-1538
93. Le J., and Vilcek J. Tumor necrosis factor and interleukin-1: Cytokines with multiple overlapping biological activities. Lab. Invest. 56 (1987) 234-248
94. Lee C.T., Fein A.M., Lippman M., et al. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N. Engl. J. Med. 340 (1981) 109-196
95. Lewis R.E., and Granger H.J. Neutrophil-dependent mediation of microvascular permeability. Fed. Proc. 45 (1986) 109-113
96. Lilly G.M., Sandu J.S., Ishizaka A., et al. Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am. Rev. Respir. Dis 139 (1989) 1361-1368
97. Louie S., Russell L.A., Teague S.V., and Cross C.E. Nasal inhalation of aerosolized lazaroid U78517F ameliorates acute ozone lung injury in rat lungs. Clin. Res. 39 (1991) 108A
98. Louie S., Arata M.A., Offerdahl S.D., and Halliwell B. Effects of tracheal insufflation of deferoxamine upon acute ozone toxicity in rats. J. Lab. Clin. Med. 121 (1993) 502-509
99. Luce J.M., Montgomery A.B., Marks J.D., et al. Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am. Rev. Respir. Dis. 138 (1988) 62-68
100. Lucht B.D., English D.K., Bernard G.R., et al. Prevention of release or granulocyte aggregants into sheep lung lymph following endotoxemia by N-acetylcysteine. Am. J. Med. Sci. 249 (1987) 161-167
101. Lynch M.J., Grum C.M., Gallagher K.P., et al. Toxic oxygen metabolites from oxidase systems cause rapid serum complement activation, RBC fragility and acute edematous oxidative lung injury in rats subjected to skin burn. Clin. Res. 36 (1988) 194A
102. Marks J.D., Marks C.B., Luce J.M., et al. Plasma tumor necrosis factor in patients with septic shock. Am. Rev. Respir. Dis. 141 (1990) 94-97
103. Martin T.R., Pistorese B.P., Hudson L.D., and Maunder R.J. The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome: Implications for the pathogenesis of lung infections. Am. Rev. Respir. Dis. 144 (1991) 254-262
104. Mason R.J. Pulmonary alveolar type II epithelial cells and adult respiratory distress syndrome. West. J. Med. 143 (1985) 611-615
105. Matuschak G.M., and Rinaldo J.E. Organ interactions in the adult respiratory distress syndrome during sepsis: Role of the liver in host defense. Chest 94 (1988) 400-406
106. Maunder R.J., and Hudson L.D. Clinical risks associated with the adult respiratory distress syndrome. In: Zapol W.M., and Lemaire F. (Eds). "Adult Respiratory Distress Syndrome" (1991), Dekker, New York 1-18
107. Maunder R.J., Shuman W.P., Mchugh J.W., et al. Preservation of normal lung regions in the adult respiratory distress syndrome: Analysis by computed tomography. JAMA 255 (1986) 2463-2465
108. Mccloskey M.D., Straube R.C., Sanders C., et al. Treatment of septic shock with human monoclonal antibody HA-1A: A randomized double-blind placebo-controlled trial. Ann. Intern. Med. 121 (1994) 1-5
109. Mccord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312 (1985) 159-161
110. Mccord J.M., Gao B., Leff J., and Flores S. Neutrophil-generated free radicals: Possible mechanisms of injury in adult respiratory distress syndrome. Environ. Health Perspect. 102 Suppl. 10 (1994) 57-60
111. Mcmillan D.D., and Boyd G.N. The role of antioxidants and diet in the prevention or treatment of oxygen-induced lung microvascular injury. Ann. N.Y. Acad. Sci. 384 (1982) 535-543
112. Meduri G.U., Eltorky M., and Winer-Muram H.T. The fibroproliferative phase of late adult respiratory distress syndrome. Semin. Respir. Infect. 10 (1995) 154-175
113. Mercat A., Graini L., Teboul J.L., Lenique F., and Richard C. Cardiorespiratory effects of pressure controlled ventilation with and without inverse ratio in the adult respiratory distress syndrome. Chest 104 (1993) 871-875
114. Michie H.R., Manogue K.R., Spriggs D.R., et al. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318 (1988) 1481-1486
115. Milberg J.A., Davis D.R., Steinberg K.P., and Hudson L.D. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 273 (1995) 306-309
116. Miles A.M., Owens M.W., Milligan S., Johnson G.G., Fields J.Z., Ing T.S., Kottapalli V., Keshavarzian A., and Grisham M.B. Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes. J. Leukocyte Biol. 58 (1995) 616-622
117. Millar A.B., Foley N.M., Singer M., Johnson N.M., Meager A., and Rook G.A.W. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2 (1989) 712-714
118. Miller E.J., Cohen A.B., Nagao S., et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146 (1992) 427-432
119. Millili J.J., and Marino P.L. Improved clinical outcome in adult respiratory distress syndrome (ARDS) treated with antioxidants. Free Rad. Bio. Med. 15 (1993) 512
120. Mizer L.A., Weisbrode S.E., and Dorinsky P.M. Neutrophil accumulation and structural changes in nonpulmonary organs after lung injury induced by phorbol myristate acetate. Am. Rev. Respir. Dis. 139 (1989) 1017-1026
121. Moldeus P., Cotgreave I.A., and Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration 50 (1986) 31-43
122. Moncada S., and Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9 (1995) 1319-1330
123. Moreno J.J., and Prior W.A. Inactivation of α-1 proteinase inhibitor by peroxynitrite. Chem. Res. Toxicol. 5 (1992) 425-431
124. Morris A.H., Wallace C.J., Menlove R.L., et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal COz removal for adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 149 (1994) 295-305
125. Moss M., Bucher B., Moore F.A., Moore E.E., and Parsons P.E. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 275 (1996) 50-54
126. Movat H.Z. Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury. J. Lab. Clin. Med. 110 (1987) 668-681
127. Murray J.F., Matthay M.A., Luce J.M., and Flick M.R. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138 (1988) 720-723
128. National Heart and Lung Institute. Respiratory diseases: Task force report on problems, research approaches, needs (1972), U.S. Government Printing Office, Washington, D.C. DHEW Publication No (NIH) 73-432:167-80
129. National Heart, Lung, and Blood Institute. Extracorporeal support for respiratory insufficiency: Collaborative study (1979), United States Department of Health, Education and Welfare. Public Health Service.
130. Ognibene F.P., Martin S.E., Parker M.M., et al. Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med. 315 (1986) 547-551
131. Pacht E.R., Timerman A.P., Lykens M.G., and Merola A.J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100 (1991) 1397-1403
132. Perlman M.B., Johnson A., Jubiz W., et al. Lipoxygenase products induce neutrophil activation and increase endothelial permeability after thrombin-induced pulmonary microembolism. Circ. Res. 64 (1989) 62-73
133. Pinkard R.N., Ludwig J.C., and Mcmanus L.M. Platelet activating factors. In: Gallin J.J., Goldstein I.M., and Snyderman R. (Eds). "Inflammation: Basic Principles and Clinical Correlates" (1988), Raven Press, New York 139-167
134. Pison U., Seeger W., Buchhorn R., et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140 (1989) 1033-1039
135. Quinlan G.J., Evans T.W., and Gutteridge J.M.C. Measurement of metatyrosine, ortho-tyrosine and kynurene in BAL proteins of patients with ARDS: Evidence for the formation of hydroxyl radicals. Thorax 50 Suppl. 2 (1995) A69
136. Rabinovici R., Sofronski P., Borborglu P., et al. Interleukin 2-induced lung injury: The role of complement. Cir. Res. 74 (1994) 329-335
137. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288 (1991) 481-487
138. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991) 4244-4250
139. Remick D.G., Kunkel R.G., Larrick J.W., and Kunkel S.L. Acute in vivo effects of human recombinant tumor necrosis factor. Lab. Invest. 56 (1987) 583-590
140. Repine J.E., and Beehler C.J. Neutrophils and adult respiratory distress syndrome: Two interlocking perspectives in 1991. Am. Rev. Respir. Dis. 144 (1991) 251-252
141. Richard C., Lemonnier F., Conturier M., Rion B., and Auzepy P. Vitamin E and selenium deficiency during acute respiratory distress syndrome. Am. Rev. Resp. Dis. 133 (1986) A203
142. Richard C., and Lemonnier F. Lipoperoxidation and vitamin E consumption during adult respiratory distress syndrome. Am. Rev. Respir. Dis. 135 (1987) 425A
143. Rinaldo J.E., English D., Levine J., Stiller R., and Henson J. Increased intrapulmonary retention of radiolabeled neutrophils in early oxygen toxicity. Am. Rev. Respir. Dis. 137 (1988) 345-352
144. Rossaint R., Falke K.J., Lopez F., et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328 (1993) 339-405
145. Rossaint R., Schmidt-Ruhnke H., Steudel W., et al. Retrospective analysis of survival in patients with severe acute respiratory distress syndrome treated with and without nitric oxide inhalation. Crit. Care Med. 23 (1995) A112
146. Rothstein J.L., and Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 607-611
147. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kick M., and Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite dependent lipid peroxidation: Formation of novel nitrogen containing oxidized lipid derivatives. J. Biol. Chem. 269 (1994) 26066-26075
148. Rubin D.B., Wiener-Kronish J.P., Murrary J.F., et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J. Clin. Invest. 86 (1990) 474-480
149. Ryan S.F., Ghassibi Y., and Liau D.F. Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am. J. Respir. Cell. Mol. Biol. 4 (1991) 33-41
150. Ryan U.S., and Vann J.M. Endothelial cells: A source and target of oxidant damage. In: Simic M.G., Taylor K.A., and Ward A.F. (Eds). "Oxygen Radicals in Biology and Medicine" (1987), Plenum, New York 963-968
151. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., and Serhan C.N. Leukotrienes and lipoxins: Structures biosynthesis, and biological effects. Science 237 (1987) 1171-1176
152. Sawyer M.A.J., Mike J.J., Chavin K., and Marino P.L. Antioxidant therapy and survival in ARDS. Crit. Care Med. 17 (1989) S153
153. Schade U.F. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ. Shock 31 (1990) 171-181
154. Seear M.D., Hannam V.L., Kaapa P., Rau J.U., and O'Brodovich H.M. Effect of pentoxifylline on hemodynamics, alveolar fluid reabsorption and pulmonary edema in a model of acute lung injury. Am. Rev. Respir. Dis. 142 (1990) 1083-1087
155. Seidenfeld J.J., Pohl D.F., Bell R.C., et al. Incidence, site and outcome of infection in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 134 (1986) 12-16
156. Sibille Y., and Reynolds H.Y. State of the art: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141 (1990) 471-501
157. Slutsky A.S. Nonconventional modes of ventilation. Am. Rev. Respir. Dis. 138 (1988) 175-183
158. Smith J.A. Neutrophils, host defense, and inflammation: A double-edged sword. J. Leukocyte Biol. 56 (1994) 672-686
159. Stephenson A.H., Lonigro A.J., Hyers T.M., Webster R.O., and Fowler A.A. Increased concentration of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am. Rev. Respir. Dis. 138 (1988) 714-719
160. Stevens J.H., O'Hanley P., Shapiro J.M., et al. Effects of anti-C5a antibodies of the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77 (1986) 1812-1816
161. Stewart T.E., Valenza F., Ribeiro S.P., et al. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am. J. Respir. Crit. Cure Med. 151 (1995) 713-718
162. Sullivan G.W., Carper H.T., Novick W.J., and Mandell G.L. Pentoxifylline inhibits the inflammatory effects of endotoxin and endotoxin-induced cytokines on neutrophil function. In: Mandell G.L., and Novick (Eds). "Pentoxifylline and Leukocyte Function" (1988), Haber and Flora, Weston, CT 37-48
163. Suter P.M., Domenighetti G., Schaller M.D., Laverriere M.C., Ritz R., and Perret C. N-Acetylcysteine enhances recovery from acute lung injury in man: A randomized, double-blind, placebo-controlled clinical study. Chest 105 (1994) 190-194
164. Suter P.M., Suter S., Girardin E., Roux-Lombard P., Grau G.E., and Dayer J.M. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145 (1992) 1016-1022
165. Takeda K.Y., and Shimada M. Plasma lipid peroxides and α-tocopherol in critically ill patients. Crit. Care Med. 12 (1984) 957-959
166. Takeda K.Y., Shimada T., Okada M., et al. Lipid peroxidation in experimental septic rats. Crit. Care Med. 14 (1986) 719-723
167. Thomsen G.E., and Morris A.H. Incidence of the adult respiratory distress syndrome in the state of Utah. Am. J. Respir. Crit. Care Med. 152 (1995) 965-971
168. Till G.O., Hatherill J.R., Tourtellotte W.W., et al. Lipid peroxidation and acute lung injury following thermal trauma to skin: Evidence for role of hydroxyl radical. Am. J. Pathol. 119 (1985) 376-383
169. Till G.O., Johnson K.J., Kunkel R., et al. Intravascular activation of complement and acute lung injury. J. Clin. Invest. 69 (1982) 1126-1135
170. Tracey K.J., Fong Y., Hesse D.G., et al. Anti-cachectin/TNFα monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330 (1987) 662-664
171. Tsuno K., Prato P., and Kolobow T. Acute lung injury from mechanical ventilation at moderately high airway pressures. J. Appl. Physiol. 69 (1990) 956-961
172. Turrens J.F., Crapo J.D., and Freeman B.A. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J. Clin. Invest. 73 (1984) 87-95
173. Van Der Vliet A., Smith D., O'Neill C.A., Kaur H., Darley-Usmar V., Cross C.E., and Halliwell B. Interactions of peroxynitrite with human plasma and its constituents: Oxidative damage and antioxidant depletion. Biochem. J. 303 (1994) 295-301
174. Varani J., Fligiel S.E.G., Till G.O., et al. Pulmonary endothelial cell killing by human neutrophils. Lab. Invest 53 (1985) 656-663
175. Vedder N.B., Winn R.K., Chi E.Y., et al. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J. Clin. Invest. 81 (1988) 939-944
176. Vesconi S., Rossi G.P., Pesenti A., et al. Pulmonary microthrombosis in severe adult respiratory distress syndrome. Crit. Care Med. 16 (1988) 111-113
177. Villar J., and Slutsky A.S. The incidence of ARDS. Am. Rev. Respir. Dis. 140 (1989) 814-816
178. Visner G.A., Dougall W.C., Wilson J.M., Burr I.A., and Nick H.S. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. J. Biol. Chem. 265 (1990) 2856-2864
179. Wagner P.D., Mathieu-Costello O., Bebout D.E., et al. Protection against pulmonary oxygen toxicity by N-acetylcysteine. Eur. Respir. J. 2 (1989) 116-126
180. Wakabayashi G., Gelfand J.A., Burke J.F., et al. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5 (1991) 338-343
181. Wang W., Suzuki Y., Tanigaki T., Rank D.R., and Raffin T.A. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am. J. Respir. Crit. Care Med. 150 (1994) 1449-1452
182. Ward P.A., Till G.O., and Beauchamp C. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J. Clin. Invest. 72 (1983) 789-801
183. Ward P.A., Till G.O., Hatherill J.R., et al. Systemic complement activation, lung injury, and products of lipid peroxidation. J. Clin. Invest. 76 (1985) 517-527
184. Warren H.S., Danner R.L., and Munford R.S. Antiendotoxin monoclonal antibodies. N. Engl. J. Med. 326 (1992) 1153-1156
185. Weiland J.E., Davis W.B., Holter J.F., et al. Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiological significance. Am. Rev. Respir. Dis. 133 (1986) 218-225
186. Weinberg P.F., Matthay M.A., Webster R.O., et al. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am. Rev. Respir. Dis. 130 (1984) 791-796
187. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 320 (1989) 365-376
188. White C.W., Ghezzi P., Dinarello C.A., et al. Recombinant TNF/cachectin and IL-1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. J. Clin. Invest. 79 (1987) 1868-1873
189. White C.W., Ghezzi P., Mcmahon S., Dinarello C.A., and Repine J.E. Cytokines increase rat lung antioxidant enzymes during exposure to hyperoxia. J. Appl. Physiol. 66 (1989) 1003-1007
190. Wink D.A., Cook J.A., Pacelli R., et al. Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol. Lett. 82/83 (1995) 221-226
191. Wizemann T.M., Gardner C.R., Laskin J.D., et al. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J. Leukocyte Biol. 56 (1994) 759-768
192. Wolf H.R.D., and Seeger H.W. Experimental and clinical results in shock lung treatment with vitamin E. Ann. N.Y. Acad. Sci. 393 (1982) 392-409
193. Yoshimoto T., Kakanishi K., Hirose S., et al. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J. Immunol. 148 (1992) 3596-3603
194. Yu M., and Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit. Care Med. 21 (1993) 1635-1642
195. Ziegler E.J., Mccutchan J.A., Fierer J., et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant. Escherichia coli. N. Engl. J. Med. 307 (1982) 1225-1230
196. Ziegler E.J., Teng N.N.H., Douglas H., et al. Treatment of Pseudomonas bacteria in neutropenic rabbits with human monoclonal Igh4 antibody against E. coli lipid A. Clin. Res. 35 (1987) 619A
197. Zurier R.B., Weissmann G., Hoffstein S., et al. Mechanisms of lysosomal enzyme release from human leukocytes. J. Clin. Invest. 53 (1974) 297-309